A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Praziquantel (Biltricide)

Anthelmintic class · 1 generic manufacturer · 1 ANDAs filed at FDA.

First FDA approval2011-04-21
Generic availableYes · 1 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$1.8M in CY2024 Part D spend2K claims · 2K beneficiaries · 329 plans surveyed

Lowest NADAC
$54.65/unit
1 NDCs benchmarked, lowest of all strengths.
Average NADAC
$54.65
Across all dosage forms in distribution.
Highest NADAC
$54.65
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Praziquantel used for?

Praziquantel is a Anthelmintic medication tracked in Medicare Part D.

Is there a generic for Praziquantel?

Yes. 1 ANDAs filed at FDA, 1 generic manufacturers currently shipping.

How much does my plan pay for Praziquantel?

Across 329 Part D plans, Praziquantel averages $54.65/unit (NADAC). Lowest available: $54.65/unit. Highest in distribution: $54.65/unit.

Is Praziquantel on the FDA shortage list?

No. Praziquantel is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Anthelmintic3 alternatives in D1
01
Albendazole
Brand: ALBENZA
$4.40Lowest NADAC
6Generic mfrs
$7.8MCY24 Part D spend
Compare →
02
Mebendazole
Brand: VERMOX
Lowest NADAC
1Generic mfrs
$10.1MCY24 Part D spend
Compare →
03
Triclabendazole
Brand: EGATEN
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (1 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.